Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001 June 28, 2023 • 4:15 PM EDT
Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference June 16, 2023 • 8:00 AM EDT
Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society May 19, 2023 • 8:30 AM EDT
Kintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Update May 11, 2023 • 8:15 AM EDT
Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting April 14, 2023 • 12:00 PM EDT
Kintara Therapeutics to Present Two Posters at the 2023 American Association for Cancer Research Annual Meeting March 15, 2023 • 8:00 AM EDT
Kintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023 March 10, 2023 • 8:30 AM EST
Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update February 14, 2023 • 5:00 PM EST